3,560 material Form 8-K filings that 2,489 companies we cover made with the SEC in October 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 2,508 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
On September 30, 2026, RenX Enterprises agreed to cancel $1,446,774.32 of debt owed to James D. Burnham, a current Director of Growth & M&A and former director, in exchange for 1,441 shares of Series D Convertible Preferred Stock and a warrant. The Series D Preferred carries a 150% liquidation preference and can convert into up to 960,666 common shares at the floor price, so the deal removes debt but adds potential dilution and a senior claim for shareholders.
Debt of $1,446,774.32 under a June 2, 2025 promissory note was cancelled in exchange for 1,441 preferred shares and a warrant.
Preferred converts at an initial $2.895 per share into 497,754 common shares; the warrant covers 124,438 common shares at $2.895 with a five-year term.
Full conversion at the $1.50 floor price could issue up to 960,666 common shares, subject to stockholder approval where Nasdaq rules require it.
Preferred dividends accrue at 8% per year, rising to 9% if not paid in cash; the Certificate of Designation was filed October 2, 2026.
Seven Hills Realty Trust (SEVN) reported it closed two first mortgage loans totaling $98.0 million and received $68.0 million from two loan repayments, reducing office exposure to about 13% of its portfolio as of September 30, 2026. One repayment, a Dallas office loan, was settled at a $1.5 million discount to its $44.2 million balance, which the company said was well below its $6.3 million CECL reserve.
Two new first mortgage loans totaling $98.0 million: $68.0 million in Chattanooga, Tennessee and $30.0 million in Charlotte, North Carolina
Dallas office loan repaid at about 97% of its $44.2 million balance, a $1.5 million discount; the company said it was well below the $6.3 million CECL reserve as of June 30, 2026
Three loans in diligence totaling $121.7 million expected to close in the fourth quarter of 2026, subject to closing conditions
Third quarter 2026 earnings conference call scheduled for October 28, 2026 at 11:00 a.m. Eastern Time
NN, Inc. closed a private placement on October 5, 2026, selling 11,275,605 common shares and pre-funded warrants for up to 4,824,395 shares at $3.30 per share, for about $50 million in net proceeds. The company said most proceeds will redeem its remaining Series D Preferred Stock, and the rest will fund business growth; shareholders face potential dilution from the new shares and resale registration.
Gross proceeds of about $53 million; net proceeds of about $50 million after a 6.0% placement agent fee and expenses
Closed October 5, 2026; 93,744,210 common shares outstanding immediately after issuance
Majority of net proceeds to redeem remaining Series D Preferred Stock; company must file resale registration statement within 45 days
Serve Robotics posted an updated investor presentation on October 5, 2026, adding preliminary, unaudited estimates of its 2026 cost of revenue of $44 million to $48 million. The presentation's plan also shows 2026 total revenue of $9 million to $10 million, so projected costs are several times projected revenue, and the auditor has not reviewed the estimates.
Preliminary 2026 cost of revenue: $44 million to $48 million, based on management estimates and not yet audited or reviewed.
Appendix plan shows 2026 total revenue of $9 million to $10 million and non-GAAP operating expenses of $140 million to $150 million.
Q2 2026 revenue was $3.2 million, and cash and marketable securities were $240 million as of June 30, 2026.
Duos Technologies sold 100% of its GPU-as-a-Service subsidiary, Duos Edge AI – GPUaaS, LLC, to Axe Compute, closing on September 30, 2026. Axe repaid the subsidiary's roughly $87.8 million of debt and agreed to pay the company $715,000 per month for 60 months, which the press release totals at $42.9 million. The company says the deal removes roughly $98.1 million of prospective equipment financing and shifts it toward owning and operating colocation sites, though the filing gives no gain, loss, or earnings effect.
Closed September 30, 2026; Axe Compute repaid the subsidiary's pre-existing debt of approximately $87.8 million.
Deferred purchase price of $715,000 per month for 60 months; repayment is due by the earlier of 12 months after closing or Axe's financing secured by the cluster.
The sold cluster comprised 288 Supermicro B300 servers (2,304 GPUs) and associated networking equipment.
Company states its 2026 outlook is unchanged: full-year revenue above $50 million and positive adjusted EBITDA.
Skyworks completed its combination with Qorvo on October 5, 2026. Each Qorvo share was converted into 0.960 Skyworks shares plus $32.50 in cash, and Skyworks says the deal is immediately accretive to non-GAAP EPS and expects $500 million or more in annualized cost synergies within 24 to 36 months. Shareholders face a larger share count and new debt, since Skyworks issued $2.0 billion of senior notes in August to fund the cash portion.
Qorvo holders receive 0.960 Skyworks shares and $32.50 in cash for each Qorvo share.
Legacy Skyworks shareholders own about 63% of the combined company and legacy Qorvo shareholders about 37%, on a fully diluted basis.
Skyworks notes issued August 10, 2026: $800 million due 2028, $600 million due 2032 and $600 million due 2036, used to finance the cash consideration.
Skyworks board expands to 11 directors; General Counsel Robert Terry's last day is October 5, 2026, and Jason K. Givens becomes SVP and General Counsel.
Vulcan Infrastructure and Power said it will redeem all outstanding 8.50% Senior Notes due 2026 on October 13, 2026, at 100% of principal plus accrued interest, which will eliminate its 2026 debt maturity. Based on preliminary, unaudited figures, the company expects cash and digital assets of about $16.9 million after the redemption and PIPE-related expenses, down from about $49.2 million as of September 30, 2026.
Remaining 2026 notes of $30,345,200 in principal are expected to be redeemed October 13, 2026, for about $30.9 million including about $523,000 of accrued interest through October 12, 2026
On October 1, 2026, $2,793,150 of 2026 notes were exchanged for $2,833,358 of 10.00% Senior Notes due 2030 and warrants for up to 1,000,000 Class A shares at $1.87 per share
Cash and digital assets were about $49.2 million as of September 30, 2026, including bitcoin of about $5.4 million; expected to fall to about $16.9 million after the redemption and about $1.4 million of PIPE expenses
INNOVATE Corp. completed the sale of its DBM Global subsidiary to IES Holdings on October 5, 2026, receiving about $413 million in cash and 430,974 IES shares valued at about $146 million. The company repaid its $20.7 million revolving credit line and said it will use the net proceeds to reduce debt, including redeeming $325 million of senior secured notes on October 15, 2026.
Seller received about $378 million in cash plus a $35 million tax-election payment, for about $413 million total cash at closing
Stock consideration of 430,974 IES shares, valued at about $146 million based on the October 2, 2026 closing price, is subject to a lock-up of up to 60 days
Redemption of $325 million of 10.500% senior secured notes scheduled for October 15, 2026; convertible notes to be redeemed on the 15th business day after the lock-up ends
Purchase price remains subject to post-closing adjustments; the Stock Consideration will not by itself be sufficient to repay debt coming due
C.H. Robinson agreed on October 4, 2026 to acquire RXO through a merger that the companies value at an implied $5.8 billion. RXO shareholders can elect $17.25 in cash plus 0.0856 C.H. Robinson shares, $30.25 in cash, or 0.1992 C.H. Robinson shares, with proration targeting about 57% cash and 43% stock. The deal is expected to close in the first half of 2027 and requires RXO stockholder approval and regulatory clearance, and C.H. Robinson expects about $300 million of net run-rate cost synergies within two years of closing.
Implied value of $5.8 billion; RXO shareholders would own about 11% of the combined company
Expected net run-rate cost synergies of about $300 million within two years after closing
C.H. Robinson will fund the cash portion with new debt and has a bridge facility from Morgan Stanley Senior Funding; it plans to pause share repurchases until reaching its target leverage
RXO would pay a $175 million termination fee in certain circumstances; the outside date is July 4, 2027, subject to two three-month extensions
Benitec Biopharma said the FDA asked for additional available data, including from the company-sponsored OPMD Natural History Study, as discussions on an open-label, single-arm pivotal study for BB-301 continue. The company said it expects to confirm the final pivotal design in the first quarter of 2027 and that the pivotal study timeline remains on track, with patient enrollment planned to begin in mid-2027.
FDA requested additional available data, including from the Benitec-sponsored OPMD Natural History Study
Final pivotal study design expected to be confirmed in 1Q 2027
Patient enrollment for the BB-301 pivotal study planned to begin in mid-2027
Interim BB-301 Phase 1b/2a results to be presented as a late-breaking poster at ESGCT in Hamburg, October 27-30, 2026
Forum Markets said it formed Forum Edge AI LLC with Edge Node AI, in which Forum holds 51% and manages the venture, to deploy AI inference compute at existing powered sites. The company also introduced full-year 2027 consolidated revenue guidance of $125 million to $175 million, and Forum will issue shares equal to 9.95% of its outstanding stock to Edge Node AI if performance milestones are met, which dilutes existing shareholders and adds financing commitments and guaranty obligations.
Forum holds 51% and Edge Node AI holds 49% of the joint venture, with Forum as sole manager.
Forum will issue Edge Node AI shares representing 9.95% of its outstanding stock, about 1.46 million shares based on 13.2 million shares outstanding as of October 2, 2026, after milestones are achieved.
Forum has committed to fund 51% of project investments and has agreed to guaranty obligations for equipment financing proportional to its interest.
The company expects to become cash flow positive in early 2027.
DocGo and its subsidiaries entered into an amended and restated credit agreement on October 1, 2026, with Perceptive Credit Holdings IV as administrative agent, replacing a prior Citibank-led revolving facility that was terminated the same day. The new term loans total $102 million in committed facilities, with a stated maturity of December 6, 2029, and the company issued a warrant for 4,000,000 shares at $0.5039 per share as part of the deal, which could dilute existing holders.
Term loans include $52 million continued from prior debt, $12.5 million new Term Loan B, $12.5 million Term Loan C tied to the Merger, and $25 million delayed draw Term Loan D
Term SOFR with a 3.50% floor plus a 7.50% margin; maturity December 6, 2029
Warrant to purchase 4,000,000 common shares at $0.5039 per share, fully vested, exercisable through the tenth anniversary of October 1, 2026
Ambulnz began managing Hicuity's non-clinical operations effective October 1, 2026; 98,992,347 common shares were outstanding as of October 1, 2026
On October 4, 2026, Profusa amended two senior secured convertible promissory notes held by Ascent Partners Fund LLC, issued April 2 and April 20, 2026. The amendments change the conversion price formula, set a fixed floor price of $0.338 per share, and set a reserve amount of 150% of potentially issuable shares for these notes, and Ascent waived certain anti-dilution protections on three later notes. The filing describes the changes as affecting potential conversions and dilution, which matters to shareholders because the share count could rise on conversion.
Amendments dated October 4, 2026 cover the April 2, 2026 note ($555,555.55 principal, $500,000 purchase price) and the April 20, 2026 note ($1,111,111.11 principal, $1,000,000 purchase price).
Conversion price is now the greater of $1.20 and 95% of the lowest daily VWAP over the five trading days before conversion, and cannot be less than the $0.338 fixed floor; previously it was a fixed $0.50 per share.
Reserve amount for these notes is 150% of the maximum shares issued or potentially issuable under the transaction documents.
Ascent waived anti-dilution provisions in Sections 5(b) and 5(c) for notes issued August 12, September 1 and September 16, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.